From: Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
Functions of Jab1 | Target proteins | Effects | References |
---|---|---|---|
Transcriptional coactivation | c-Jun | Regulating AP-1 transcriptional activity | Claret et al. (1996) |
Bcl-3 | Facilitating the formation of NF-κB/p50 and DNA complex | Dechend et al. (1999) | |
HAND2 | Augmenting HAND2 transcriptional activity by enhancing HAND2 DNA binding | Dai et al. (2004) | |
LFA-1 | LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity | Bianchi et al. (2000) | |
Brn-2 | Regulating Brn-2 DNA-binding activity | Huang et al. (2005) | |
5-HT(6)R | 5-HT(6)R induced the translocation of Jab1 into the nucleus and increased c-Jun phosphorylation and the interaction between Jab1 and c-Jun | Yun et al. (2010) | |
Fank1 | Suppressing cell apoptosis by activating the AP-1-induced anti-apoptotic pathway | Wang et al. (2011) | |
MIF | Inhibiting AP-1 activity | Kleemann et al. (2000) | |
E2F1 | Jab1 is an cofactor for E2F1 dependent transcription of apoptotic and mitotic genes | ||
DeNEDDylation | Cullins | Modulating the activity of CRLs | |
MsrA | Enhancing JAB1’s deneddylase activity | Jiang et al. (2020) | |
Deubiquitination | ANGPTL2 | Inhibiting ANGPTL2 degradation | Xie et al. (2021) |
PD-L1 | Inhibiting PD-L1 degradation | Lim et al. (2016) | |
EGFR | Inhibiting EGFR degradation | Wan et al. (2019) | |
Survivin | Inhibiting survivin degradation | Li et al. (2018) | |
HK2 | Inhibiting HK2 degradation | Huang et al. (2020) | |
FOXM1 | Inhibiting FOXM1 degradation | Mao et al. (2019) | |
ZEB1 | Inhibiting ZEB1 degradation | Zhang et al. (2017) | |
p97/VCP | Controling the ubiquitination status of proteins bound to p97/VCP | Cayli et al. (2009) | |
ABCA1 | Inhibiting ABCA1 degradation | Azuma et al. (2009) | |
Protein interactions | p53 | Promoting p53 nuclear export and degradation | |
CENP-T and CENP-W | Promoting the ubiquitin-dependent degradation of CENP-T and CENP-W | Chun et al. (2013) | |
HIF-1α | Stabilizing HIF-1 alpha aerobically by inhibiting HIF-1 alpha prolyl-hydroxylation | Bemis et al. (2004) | |
STAMBPL1 | Required for the stabilisation and function of STAMBPL1 | Chaithongyot and Naumann (2022) | |
Malt1 and Carma1 | Enhancing the stability of Carma1-Bcl10-Malt1 (CBM) complex | Welteke et al. (2009) | |
p27 | Promoting cytoplasmic shuttling and subsequent degradation of p27 | Tomoda et al. (2002) | |
Sec6 | Promoting p27 degradation in the cytoplasm via interaction with Jab1 | Tanaka and Iino (2014) | |
Rig-G | Regulating JAB1 cellular distribution through interacting with this protein and increases the intracellular level of p27 | Xiao et al. (2006) | |
PGP9.5 (UCH-L1) | Contributing to p27 degradation via its interaction and nuclear translocation with Jab1 | Caballero et al. (2002) | |
53BP1 | Required for mitotic checkpoint activation via its involvement in hyperphosphorylation of 53BP1 | Kwak et al. (2005) | |
RUNX3 | Inducing RUNX3 nuclear export and degradation | Kim et al. (2009) | |
Smad7 | Inducing Smad7 nuclear export and degradation | Kim et al. (2004) | |
TRAF-2 | Regulating lysine-63-linked polyubiquitin of TNF receptor-associated-factor 2 which in turn induce TNF-α signaling activation | Wang et al. (2006) | |
MDM2 | Regulating stabilization of MDM2 through inhibiting MDM2 self-ubiquitination | Zhang et al. (2008) | |
HBx | HBx interacts with Jab1 and trigger AP-1 activation | Tanaka et al. (2006) | |
LHR precusor | Promoting LHR precusor degradation | Li et al. (2000) | |
Smad4 | Induces its Smad4 ubiquitylation and degradation | Wan et al. (2002) | |
ERα | Increasing ligand-induced ERα degradation | Callige et al. (2005) | |
Cyclin E | Promoting Cyclin E degradation | Doronkin et al. (2002) | |
CDK2 | Inhibiting CDK2 phosphorylation via AKT pathway | Yoshida et al. (2013) | |
Myc | Promoting MYC ubiquitination and degradation | Adler et al. (2006) | |
MIF | MIF stabilize p27Kip1 by interacting with Jab1; JAB1 inhibits MIF secretion | ||
DNA topoisomerase (topo) II α | Promoting topo II α degradation | Yun et al. (2004) | |
ET(A)R and ET(B)R | Promoting ET(A)R and ET(B)R ubiquitination and degradation | Nishimoto et al. (2010) | |
Smad5 | Inhibiting Smad5-mediated BMP signaling activation | Haag and Aigner (2006) | |
PR and SRC-1 | Stabilizing PR-SRC-1 complexes | Chauchereau et al. (2000) | |
SMYD3 | Jab1-SMYD3 complex activates p16INK4a transcription | Mori et al. (2008) | |
NCoR | Promoting ubiquitination and proteasome-mediated degradation of NCoR | Lu et al. (2016) | |
PAR-2 | Promoting PAR-2-induced activation of AP-1 | Luo et al. (2006) | |
Rad51 | Directly affecting Rad51-p53-binding, stabilizing Rad51 and promoting HR DNA repair | Tian et al. (2010) | |
CD89 | Increasing CD89 surface expression | Bakema et al. (2010) | |
CPNE1 | JAB1 activates the neuronal differentiation through binding to CPNE1 | Yoo et al. (2018) | |
TRAF2 | JAB1 regulates ubiquitination of TRAF2 | Wang et al. (2006) | |
Thioredoxin | Stabilizing thioredoxin under oxidative stress | Zhou et al. (2017) | |
Id3 | Mouse Jab1 was identified to interact with Id3 but the effect remains unclear | Bounpheng et al. (2000) | |
NLRP3 | Possibly promoting NLRP3 inflammasome activation | Dai et al. (2020) | |
Trc8 | Trc8 physically interacts with CSN-5 and regulate JAB1 localization | Gemmill et al. (2002) | |
PDLIM2 | PDLIM2 interacts with CSN5 and regulate CSN activity | Bowe et al. (2014) | |
CSNAP | CSNAP binds CSN3, CSN5, and CSN6, thereby regulates the function of CSN complex | Rozen et al. (2015) |